Multi-chamber container

The multi-chamber container addresses the issue of unmixed drug administration by incorporating a seal-covered hanging hole and strategic displays, ensuring users follow mixing procedures through clear, multi-angle instructions, thereby preventing oversight.

JP2024165311APending Publication Date: 2024-11-28OTSUKA PHARMACEUTICAL FACTORY INC
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2023081412
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-17
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing multi-chamber containers risk administering unmixed medicinal solutions due to user forgetfulness or oversight in mixing drugs, despite existing alert systems being insufficiently effective.

Method used

A multi-chamber container design featuring a hanging hole covered by a seal, with strategic displays on the container body and seal guiding the user through multiple steps for mixing drugs, ensuring visibility from multiple angles and preventing oversight.

Benefits of technology

The design effectively prevents users from forgetting to mix medicinal solutions by providing clear, multi-step instructions visible from various angles, enhancing user compliance and ensuring proper drug mixing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024165311000001_ABST
    Figure 2024165311000001_ABST
Patent Text Reader

Abstract

To provide a multi-chamber container that prevents a user to forget medicine liquid mixture work before administration of medicine liquid.SOLUTION: A multi-chamber container provided with a suspension hole includes: a container body having a first storage part storing a first medicine, a second storage part storing a second medicine, and a peelable partition part partitioning the first storage part and the second storage part; and a seal covering the suspension hole. In each of the container body and the seal, a measure for mixing the first medicine and the second medicine is displayed.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a multi-chamber container. [Background technology]

[0002] Conventionally, there have been known multi-chamber containers having multiple chambers for mixing two or more kinds of medicinal liquids to be administered to a patient by intravenous injection under a sterile condition. In such multi-chamber containers, the medicinal liquids are separately contained in multiple chambers separated by peelable partitions. For this reason, the partitions are peeled off immediately before using the multi-chamber container. This allows the chambers to communicate with each other and mix the medicinal liquids.

[0003] When a user of a multi-chamber container forgets to mix the medicinal liquids or thinks that they have mixed them, problems may occur in which unmixed medicinal liquids are administered to a patient. Various ideas have been devised to prevent such problems from occurring. For example, the following Patent Document 1 describes providing a display on the surface of the medicine chamber to encourage the user to apply pressure to mix the medicinal liquids. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] JP 2007-244660 A Summary of the Invention [Problem to be solved by the invention]

[0005] It can be said that the use of a multi-chamber container as disclosed in the above-mentioned Patent Document 1 is effective in calling the user's attention to mixing drug solutions. However, there is room for improvement in order to more fully call attention to prevent the occurrence of the above-mentioned problems more reliably.

[0006] An object according to one aspect of the present invention is to provide a multi-chamber container that can prevent a user from forgetting to mix medicinal liquids before administering the medicinal liquids. [Means for solving the problem]

[0007] A multi-chamber container according to one aspect of the present invention is a multi-chamber container provided with a hanging hole, and comprises a container body having a first storage section in which a first drug is stored, a second storage section in which a second drug is stored, and a peelable partition section separating the first storage section and the second storage section, and a seal covering the hanging hole, and each of the container body and the seal indicates a method for mixing the first drug and the second drug.

[0008] In this multi-chamber container, the container body displays the measures for mixing the first medicine and the second medicine. This allows the user to easily confirm the measures for mixing the first medicine and the second medicine when starting to use the multi-chamber container. In addition, the hanging hole provided in the multi-chamber container is covered with a seal. Therefore, when the user hangs the multi-chamber container using the hanging hole, at least a part of the seal is removed from the container body (for example, peeled off or cut off). Here, the above measures are also displayed on the seal. Therefore, the user can easily confirm the above measures even when visually checking the seal during the seal removal operation. In this way, when using the multi-chamber container, the user can confirm the above measures at multiple times, so that the mixing operation of the first medicine and the second medicine before administration of the medicinal liquid is unlikely to be overlooked. Therefore, by using the multi-chamber container, it is possible to effectively prevent the user from forgetting to mix the medicinal liquid before administration of the medicinal liquid.

[0009] The measure may include multiple steps for mixing the first and second drugs, so that the user can properly perform the drug mixing task even if the mixing task is complicated.

[0010] The seal may have a covering portion covering the hanging hole, and the measures indicated on the seal may further include a procedure for exposing the hanging hole. In this case, when the user removes the seal to use the hanging hole, the user is more likely to visually recognize the measures indicated on the seal. Thus, the mixing operation of the first drug and the second drug before administration of the medicinal solution is less likely to be overlooked. In addition, the user can properly perform the exposure process of the hanging hole by checking the above procedure.

[0011] The multi-chamber container may further include a flap portion having a hanging hole and extending from an upper edge of the container body, and the seal may fix the flap portion onto the container body. In addition, the width of the flap portion may be smaller than the width of the container body, and the seal may cover the flap portion. In this case, the flap portion can be reliably fixed onto the container body.

[0012] The seal may be provided with a first mixing promotion marking to promote mixing of the first drug and the second drug, and a second mixing promotion marking to promote mixing of the first drug and the second drug may be provided on the back surface of the flap portion opposite to the surface to which the seal is attached. In this case, when using the multi-chamber container, the user can check the mixing promotion marking from both the front and back sides of the multi-chamber container. This makes it more difficult to overlook the mixing of the first drug and the second drug before administering the medicinal solution.

[0013] When viewed from the front, the size of the seal is 5% to 30% of the size of the container body, and in addition to the measures, the seal is provided with a mixing promotion display that promotes mixing of the first medicine and the second medicine, and the size of the characters included in the measures and the size of the characters included in the mixing promotion display on the seal may be 7 pt or more and 72 pt or less from the viewpoint of visibility. In this case, both the characters included in the measures for mixing the first medicine and the second medicine and the characters included in the mixing promotion display on the seal are easily visible to the user. Therefore, the mixing operation of the first medicine and the second medicine before administration of the medicinal liquid is less likely to be overlooked. In addition, the size of the seal is such that all of the above characters can be written.

[0014] When the measures are displayed on the surface of the container body and the seal fixes the flap portion onto the container body, the orientation of the letters included in the measures displayed on the container body and the orientation of the letters included in the measures displayed on the seal may be the same in the up-down direction. In this case, a user of the multi-chamber container can see the measures from either the front or back side of the container body.

[0015] When the container body is folded along the partition, the measures indicated on the container body and the measures indicated on the sticker may be both visible, so that a user can easily see both of the measures even when the multi-chamber container is folded.

[0016] In the container body, a part of the measure is displayed on a first portion overlapping the first storage portion, and another part of the measure is displayed on a second portion overlapping the second storage portion, and the partition may be peeled off by pressing the first portion or the second portion. In this case, even if the first portion or the second portion cannot be seen during the pressing operation by the user, the user can see at least a part of the measure. Effect of the Invention

[0017] Advantageous Effects of Invention According to one aspect of the present invention, it is possible to provide a multi-chamber container that can prevent a user from forgetting to mix medicinal liquids before administering the medicinal liquids. [Brief description of the drawings]

[0018] [Figure 1] FIG. 1 is a front view of a multi-chamber container according to an embodiment. [Diagram 2] FIG. 2 is a rear view of the multi-chamber container according to the embodiment. [Diagram 3] FIG. 3 is a front view of the multi-chamber container immediately prior to use. [Figure 4] FIG. 4 is an enlarged view of the seal. [Diagram 5] FIG. 5 shows a multi-chamber container in a folded state. [Figure 6] FIG. 6 is a rear view of a multi-chamber container according to a modified example immediately before use. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0019] Hereinafter, a preferred embodiment of one aspect of the present invention will be described in detail with reference to the accompanying drawings. In the following description, the same elements or elements having the same functions will be denoted by the same reference numerals, and duplicated descriptions will be omitted.

[0020] FIG. 1 is a front view of a multi-chamber container according to an embodiment. FIG. 2 is a rear view of a multi-chamber container according to an embodiment. FIG. 3 is a front view of a multi-chamber container immediately before use. In FIG. 1 and FIG. 2, a multi-chamber container before use is shown, and in FIG. 3, a multi-chamber container immediately before use is shown. The multi-chamber container 1 shown in FIG. 1 to FIG. 3 is a container that independently accommodates, for example, a plurality of medicinal liquids for infusion. The multi-chamber container 1 has a container body 2, a flap portion 3 extending from one end 2a of the container body 2, a hanging hole 4 provided in the flap portion 3, a seal 5 covering the hanging hole 4, a port 6 connected to the inside of the container body 2, and a seal 7 closing the tip 6a of the port 6. Hereinafter, the direction X shown in FIG. 1 to FIG. 3 is the vertical direction of the multi-chamber container 1, and the direction Y is the width direction of the multi-chamber container 1. In addition, the direction perpendicular to both directions X and Y is the thickness direction of the multi-chamber container 1. Therefore, one end 2a of the container body 2 corresponds to the upper edge of the container body 2.

[0021] The container body 2 is a bag-shaped molded member exhibiting flexibility. The shape of the container body 2 is not particularly limited, but is, for example, approximately rectangular. The container body 2 is formed, for example, by thermally bonding two films exhibiting flexibility. The film is a plastic film exhibiting transparency and flexibility, and may have a single-layer structure or a laminated structure. When the film has a laminated structure, the film includes, for example, an outer layer which is a polyethylene film, an intermediate layer which is a polycyclic olefin film, and an inner layer which is a mixed film of polyethylene and polypropylene. The dimension of the container body 2 along the direction X is, for example, 15 cm or more and 30 cm or less, and the dimension of the container body 2 along the direction Y is, for example, 15 cm or more and 25 cm or less. Therefore, the area of ​​the container body 2 in a front view is, for example, 225 cm 2 More than 750cm 2 From the viewpoint of the capacity of each drug, the above area is, for example, 400 cm 2 That is all. In this specification, "transparent" means that the transmittance of visible light is a predetermined percentage or more (for example, 55% or more). In other words, in this specification, "transparent" is a concept that also includes translucency. In addition, at least a part of the film may be colored.

[0022] The container body 2 has a first storage section 21, a second storage section 22, and a removable partition section 23 that separates the first storage section 21 and the second storage section 22. The first storage section 21 is a section in which the first medicine is stored, and is defined by the outer edge 2b of the container body 2 and the partition section 23. The first storage section 21 is located below the partition section 23 and communicates with the port 6. The second storage section 22 is a section in which a second medicine different from the first medicine is stored, and is defined by the outer edge 2b of the container body 2 and the partition section 23. The second storage section 22 is located above the partition section 23. The first medicine and the second medicine are stored in the container body 2 independently of each other, so that the first medicine and the second medicine, which are less stable when mixed and stored for a long period of time, can be stored in an unmixed state. This can suppress deterioration of the first medicine and the second medicine.

[0023] Each of the first drug and the second drug is a liquid, solid (including powder, gel, etc.), or gas content. In this embodiment, each of the first drug and the second drug is transparent, but is not limited thereto, and may be translucent or opaque. Each of the first drug and the second drug may be colorless or colored. From the viewpoint of ease of peeling off the partition part 23, it is preferable that at least one of the first drug and the second drug is a drug solution. In this embodiment, each of the first drug and the second drug is a drug that is generally used as an infusion (for example, a nutritional infusion for intravenous administration). When each of the first drug and the second drug is a nutritional infusion for intravenous administration, for example, the first drug is a sugar solution and the second drug is an amino acid solution. The nutritional infusion for intravenous administration may be an infusion such as a nutritional infusion for central venous administration or a nutritional infusion for peripheral venous administration. The sugar contained in the sugar solution is, for example, a reducing sugar, or may be glucose. The sugar solution may contain electrolytes, pH adjusters, and water-soluble vitamins such as vitamins B1, B2, B6, and B12 in addition to sugar. The sugar solution may contain fat-soluble vitamins such as vitamins A, D, and E together with a surfactant. The composition, pH, and the like of the sugar solution can be appropriately changed depending on the pathological condition of the patient. The amino acids contained in the amino acid solution may be the amino acids themselves or amino acid derivatives such as N-acetyl derivatives. The amino acid solution may contain electrolytes, pH adjusters, and water-soluble vitamins such as vitamin C in addition to amino acids. The composition, pH, and the like of the amino acid solution can be appropriately changed depending on the pathological condition of the patient. Alternatively, the first drug and the second drug may be a perfusion solution, a dialysis solution, or a preservation solution.

[0024] The partition 23 is a weak seal portion that can be peeled off by applying pressure to the container body 2 (for example, a pressing force in the thickness direction by the user against the first storage section 21 or the second storage section 22). When the partition 23 is peeled off, the first storage section 21 and the second storage section 22 communicate with each other, and the first drug and the second drug are mixed. The partition 23 extends along the direction Y and separates the first storage section 21 and the second storage section 22. The partition 23 has a central section 23a in the direction Y and a pair of side sections 23b, 23b that sandwich the central section 23a in the direction Y. In the direction X, the width of the central section 23a is smaller than the width of each side section 23b. In addition, at least a part of the width of each side section 23b becomes narrower as it approaches the central section 23a. As a result, when the pressure is applied to container body 2, the first drug or the second drug tends to gather in central portion 23a, making central portion 23a more likely to be peeled off.

[0025] As shown in FIG. 1, a method 100 for mixing a first drug and a second drug is displayed on the surface of the container body 2. The method 100 is a display including at least one of characters, colors, symbols, and figures, and is printed, for example, on the surface of the container body 2. The characters are Japanese, English, simplified characters, traditional characters, numbers, etc. In this embodiment, the method 100 displays at least one of white characters, symbols, and figures on a red background. The orientation of the characters included in the method 100 displayed on the container body 2 is upright when viewed from the front. The method 100 includes multiple procedures for mixing a first drug and a second drug. In this embodiment, the method 100 includes a first procedure 101, a second procedure 102, and a third procedure 103. A first step 101 (a part of the measure 100) is displayed on a first portion 2c of the container body 2 overlapping the first storage section 21 in the thickness direction, and on a central portion 2f of the container body 2 overlapping the partition section 23 in the thickness direction. A second step 102 (another part of the measure 100) and a third step 103 (another part of the measure 100) are displayed on a second portion 2d and a third portion 2e of the container body 2 overlapping the second storage section 22 in the thickness direction, respectively. Note that the measure 100 is omitted in FIG. 2. In addition, a display different from the measure 100 (for example, a display indicating the product name, a display indicating the volume of the contents, etc.) may be provided on the surface of the container body 2.

[0026] The first step 101, the second step 102, and the third step 103 each specifically explain the mixing operation of the first drug and the second drug. The first step 101 includes an indication 101a indicating the place where the container body 2 is pressed when starting to use the multi-chamber container 1, an indication 101b indicating the direction of the force transmitted when the container body 2 is pressed, and an indication 101c indicating that the partition section 23 is to be opened. The indications 101a and 101b are provided on the first part 2c, and the indication 101c is provided on the central part 2f. The indication 101a overlaps the central part of the first storage section 21, but is not limited to this. For example, in the direction X, the indication 101a may be closer to the port 6 than the center of the first storage section 21, or may be closer to the partition section 23 than the center of the first storage section 21. For example, the user can easily peel off the partition section 23 by pressing the first part 2c according to the content of the indication 101a. At this time, when the user places his / her hand on the first portion 2c, the mark 101a is hidden, but at least a part of the mark 101b and the mark 101c provided on the central portion 2f are not hidden. From the viewpoint of peeling off the partition portion 23 by pressing the first portion 2c and checking the mark 101c when the first portion 2c is pressed, the marks 101a and 101c are preferably as far apart from each other as possible. Each of the marks 101a, 101b, and 101c includes at least one of a character and a figure, but is not limited thereto. The second step 102 includes an indication indicating that the first drug and the second drug are to be mixed. In this embodiment, the indication of the second step 102 is highly related to the indications 101a and 101b of the first step 101. For this reason, the second step 102 may be located near the first step 101 in the second storage section 22. For example, the indication 101b indicating the direction of the force transmitted during compression may be provided not only on the first portion 2c but also on the second portion 2d. In this case, the second step 102 may be displayed overlapping the indication 101b. The third step 103 includes an indication to peel off the covering portion 51 (described in detail later) included in the seal 5 to expose it in the hanging hole 4. In this embodiment, the third step 103 has a content less related to the first step 101 than the second step 102. Therefore, the third step 103 may be located farther from the first step 101 than the second step 102. In this embodiment, the third portion 2e is located farther from the first portion 2c than the second portion 2d.From the viewpoint of allowing the user to check each display in a short time, the number of characters included in each of the displays 101a, 101b, and 101c, the second procedure 102, and the third procedure 103 is, for example, 8 characters or less, or 6 characters or less.

[0027] The flap portion 3 is a portion formed simultaneously with the outer edge 2b of the container body 2, and is provided with a hanging hole 4. As shown in FIG. 1 and FIG. 2, in the multi-chamber container 1 before use, the flap portion 3 is folded toward the second storage portion 22. On the other hand, as shown in FIG. 3, in the multi-chamber container 1 immediately before use, the flap portion 3 extends from the upper edge of the container body 2 in the direction X away from the container body 2. Here, in the multi-chamber container 1 before use, the flap portion 3 is fixed to the back surface of the container body 2 by the seal 5. In other words, in the multi-chamber container 1 before use, the seal 5 is attached to the flap portion 3 and the back surface of the container body 2 without being damaged. This allows the flap portion 3 to be reliably fixed to the container body 2 even when a large number of multi-chamber containers 1 are packed in a box. In addition, the portion of the seal 5 that blocks the hanging hole 4 is difficult to remove, so that unintended operations on the multi-chamber container 1, such as removing the above-mentioned portion of the seal 5 by an operator before performing the opening operation of the partition portion 23, can be prevented. Furthermore, by fixing the flap portion 3 with the seal 5, damage to the multi-chamber container 1 caused by the flap portion 3 can be suppressed. The width of the flap portion 3 along the direction Y is smaller than the width of the container body 2. This makes it possible to effectively suppress damage to the multi-chamber container 1 caused by the flap portion 3 when the flap portion 3 is folded, for example. For example, the width of the flap portion 3 is 70% or more and 90% or less of the width of the container body 2.

[0028] The hanging hole 4 is a portion provided for hanging the multi-chamber container 1 on a hook of a stand, etc. The hanging hole 4 is provided, for example, in the center of the flap portion 3 in the direction Y, and has a circular shape when viewed from the front.

[0029] FIG. 4 is an enlarged view of the seal. As shown in FIG. 2 and FIG. 4, the seal 5 is a member that fixes the flap portion 3 on the container body 2 in the multi-chamber container 1 before use and covers the hanging hole 4. The seal 5 is a flexible, band-shaped sheet member that is attached to the back surface of the container body 2 and the flap portion 3. When the flap portion 3 is fixed on the container body 2, the seal 5 covers the flap portion 3. This can prevent unintended operation of the multi-chamber container 1 and can suppress damage to the container body 2, etc. caused by the corners of the flap portion 3, etc. The material that constitutes the seal 5 is not particularly limited, and examples thereof include paper, synthetic paper, art paper, cloth, and plastic films such as polypropylene and polyethylene.

[0030] When viewed from the front, the size of the seal 5 is, for example, 5% to 30% of the size of the container body 2, and may be 10% to 20%. When the size of the seal 5 is 5% or more of the size of the container body 2, the various indications described in detail below can be provided sufficiently. The lower limit of the seal size is, for example, 8%, 10%, or 12% of the size of the container body 2. The upper limit of the seal size is, for example, 25%, 22%, 20%, 18%, or 16% of the size of the container body 2. In the direction X, the dimension of the seal 5 is, for example, 5% to 20% of the dimension of the container body 2. In the direction Y, the dimension of the seal 5 is, for example, 85% to 95% of the dimension of the container body 2. The area of ​​the seal 5 when viewed from the front is, for example, 50 cm 2 More than 100cm 2 The following is the result.

[0031] The seal 5 is provided with a covering portion 51 configured to be able to open the hanging hole 4 when in use, and a slit 52 (first easy-to-tear treated portion) located at least partially around the covering portion 51. In the multi-chamber container 1 before use, the covering portion 51 is a portion that covers the hanging hole 4. The covering portion 51 is provided with an indication indicating the position of the hanging hole 4, but is not limited to this. Due to the presence of the slit 52, the hanging hole 4 is easily opened when the covering portion 51 is pressed. After the hanging hole 4 is opened, a portion of the covering portion 51 may be connected to the seal 5. In this case, the hanging hole 4 can be opened without cutting the covering portion 51 from the seal 5, thereby reducing the amount of waste.

[0032] The seal 5 is provided with a perforation 53 (second easy-tear processing portion) that releases the fixation of the flap portion 3 by the seal 5 when the first storage section 21 is compressed. This allows the partition section 23 to be peeled off by the compression and the fixation of the flap portion 3 to be released at the same time. This simplifies the procedure for using the multi-chamber container 1. The perforation 53 is provided, for example, along the entire edge of the flap portion 3. In this case, the fixation of the flap portion 3 by the seal 5 can be easily released.

[0033] The seal 5 displays a method 200 for mixing the first drug and the second drug, similar to the container body 2. In addition, the seal 5 is provided with an indication 210 (mixing promotion indication) that encourages mixing of the first drug and the second drug.

[0034] The measure 200 is a display including at least one of a character, a symbol, and a figure, and is printed, for example, on the surface of the seal 5. In this embodiment, the measure 200 displays at least one of a white character, a symbol, and a figure on a red background. As shown in FIG. 2, before the flap portion 3 is released, the orientation of the characters included in the measure 200 displayed on the seal 5 is upright when viewed from the front. Therefore, in the multi-chamber container 1 before use, the orientation of the characters included in the measure 100 displayed on the container body 2 and the orientation of the characters included in the measure 200 displayed on the seal 5 are the same in the direction X. On the other hand, when the flap portion 3 is released and the multi-chamber container 1 is about to be used as shown in FIG. 3, the orientation of the characters included in the measure 100 and the orientation of the characters included in the measure 200 are opposite to each other in the direction X. As described above, the container body 2, the first medicine, and the second medicine are each transparent. 5, when the container body 2 is folded along the partition 23 so that the seal 5 is located on the inside, both the characters included in the measure 100 and the characters included in the measure 200 are recognizable when viewed from the front. At this time, the orientation of the characters included in the measure 100 and the orientation of the characters included in the measure 200 are opposite to each other in the direction X.

[0035] The measure 200 includes a plurality of steps for mixing the first drug and the second drug, similar to the measure 100. This allows the user of the multi-chamber container 1 to understand the steps for mixing the first drug and the second drug from both the seal 5 and the container body 2. In this embodiment, the measure 200 includes a first step 201 indicating that the partition part 23 is opened when the multi-chamber container 1 is started to be used, a second step 202 indicating that the first drug and the second drug are mixed, and a third step 203 for peeling off the covering part 51 to expose it to the hanging hole 4. The first step 201 corresponds to the first step 101 of the measure 100, the second step 202 corresponds to the second step 102 of the measure 100, and the third step 203 corresponds to the third step 103 of the measure 100. The first step 201 differs from the first step 101 in that the first step 201 does not have a mark corresponding to the mark 101a indicating the place to be pressed and a mark corresponding to the mark 101b indicating the direction of the force transmitted when the container body 2 is pressed. The first step 201, the second step 202, and the third step 203 are arranged in this order in the direction Y, but are not limited to this. For example, the third step 203, the first step 201, and the second step 202 may be arranged in this order.

[0036] The display 210 is a display that guides the user to mix the first drug and the second drug (i.e., to open the partition 23). The orientation of the characters included in the display 210 is inverted when viewed from the front. Therefore, as shown in FIG. 3, the content of the display 210 can be easily recognized when viewed from the front on the multi-chamber container 1 immediately before use. Therefore, for example, when the multi-chamber container 1 is hung on a hook or the like through the hanging hole 4, the display 210 can fully demonstrate its function of calling attention to whether the first drug and the second drug are mixed. The display 210, i.e., the mixing promotion display (first mixing promotion display), includes characters that call attention to the above-mentioned mixing, such as "check opening". The display 210 may also include character strings such as "unopened, not usable".

[0037] In this embodiment, the surface of the seal 5 includes a first region 54 in which the measure 200 is displayed and a second region 55 in which the display 210 is displayed. The first region 54 and the second region 55 are spaced apart from each other and do not overlap the slit 52 and the perforation 53. The ratio of the first region 54 to the seal 5 is, for example, 30% or more, and the ratio of the second region 55 to the seal 5 is, for example, 25% or more. In this case, the measure 200 and the display 210 are each shown naturally. In addition, the ratio of the measure 200 (i.e., the first step 201, the second step 202, and the third step 203) to the first region 54 is, for example, 30% or more. This allows a user who sees the seal 5 (particularly the first region 54) to easily focus on the measure 200. In addition, the measure 200 can be easily skimmed over, so that the method of using the multi-chamber container 1 can be easily confirmed. On the other hand, the proportion of the display 210 in the second region 55 is 60% or more. This makes it difficult for a user who sees the sticker 5 (particularly the second region 55) to overlook the warning given by the display 210.

[0038] The first region 54 includes a first portion 54a in which the first step 201 and the second step 202 are displayed, and a second portion 54b that is continuous with the first portion 54a and in which the third step 203 is displayed. The first portion 54a is located, for example, closer to one end of the seal 5 in the direction Y than the covering portion 51. The shape of the first portion 54a is not particularly limited, but may be, for example, a substantially rectangular shape. The second portion 54b is located, for example, below the covering portion 51 in the direction X and extends along the direction Y. Therefore, a part of the second portion 54b is located closer to the other end of the seal 5 in the direction Y than the covering portion 51. The shape of the second portion 54b is not particularly limited, but may be, for example, a substantially rectangular shape. The proportion of the first portion 54a in the first region 54 and the proportion of the second portion 54b in the first region 54 are not particularly limited, but may both be 30% or more. The second region 55 is located on the other side of the hanging hole 4 in the Y direction and is located above the second portion 54b in the X direction, for example.

[0039] In the sticker 5, the size of the characters indicating the measure 200 and the size of the characters indicating the display 210 are each 7 pt or more and 72 pt or less. In this case, the user can easily check both the measure 200 and the display 210. The size of the characters indicating the measure 200 and the size of the characters indicating the display 210 may be 10 pt or more, 18 pt or more, 24 pt or more, 36 pt or more, 64 pt or less, 56 pt or less, 48 ​​pt or less, or 40 pt or less. From the viewpoint of allowing the user to check each display in a short time, the number of characters included in each of the first step 201, the second step 202, the third step 203, and the display 210 is, for example, 8 characters or less, or 6 characters or less. In this embodiment, the color of the characters indicating the measure 200 and the color of the characters indicating the display 210 are different from each other. This makes it difficult for a user with color vision deficiency to overlook both the measure 200 and the display 210. Note that 1 pt (point) corresponds to 1 / 72 inch (approximately 0.35 mm). In addition, from the viewpoint of calling the user's attention to the mixing operation, the size of the characters included in the mixing promotion display may be larger than the size of the characters included in the measure.

[0040] The port 6 is a drug discharge port for discharging the contents of the container body 2 (e.g., the first drug or a mixed drug solution of the first drug and the second drug), and is provided at the lower end of the multi-chamber container 1. The port 6 is, for example, a plastic member having a cylindrical shape. The port 6 is provided with a sealing plug (not shown) that can be pierced with a hollow needle, for example, and that closes the outlet of the port 6. In addition, a seal 7 is attached to the tip 6a of the port 6. The sealing plug and the extraction port are exposed by peeling off the seal 7. The mixture of the first drug and the second drug in the container body 2 can be discharged by inserting a hollow needle into the extraction port.

[0041] In the multi-chamber container 1 according to the present embodiment described above, the container body 2 displays the method 100 for mixing the first drug and the second drug. This allows the user to easily confirm the specific method 100 for mixing the first drug and the second drug when starting to use the multi-chamber container 1. In addition, the hanging hole 4 provided in the multi-chamber container 1 is covered by the seal 5. Therefore, when the user hangs the multi-chamber container 1 using the hanging hole 4, at least a part of the seal 5 is removed from the container body 2 (for example, peeled off, cut off, etc.). Here, the method 200 is also displayed on the seal 5. Therefore, even when the user visually checks the seal 5 during the removal operation of the seal 5, the user can easily confirm the simple method 200 for mixing the first drug and the second drug. In this way, when using the multi-chamber container 1, the user can confirm the methods 100, 200 at multiple times, so that the mixing operation of the first drug and the second drug before administration of the medicinal liquid is less likely to be overlooked. Therefore, by using the multi-chamber container 1, it is possible to effectively prevent the user from forgetting to mix the medicinal liquids before administering the medicinal liquids.

[0042] In this embodiment, each of the strategies 100 and 200 includes multiple procedures for mixing the first and second drugs, so that the user can properly perform the drug solution mixing task even if the mixing task is complicated.

[0043] In this embodiment, the seal 5 has a covering portion 51 that covers the hanging hole 4, and the measure 200 displayed on the seal 5 further includes a third step 203 for exposing the hanging hole 4. Therefore, when the user peels off the seal 5 to use the hanging hole 4, the possibility that the user will visually recognize the measure 200 described on the seal 5 is increased. Therefore, the mixing operation of the first drug and the second drug before administration of the medicinal solution is less likely to be overlooked. In addition, the user can properly perform the exposing step of the hanging hole 4 by checking the third step 203.

[0044] In this embodiment, the multi-chamber container 1 includes a flap portion 3 having a hanging hole 4 and extending from one end 2a of the container body 2, and the seal 5 fixes the flap portion 3 onto the container body 2. In addition, the width of the flap portion 3 is smaller than the width of the container body 2, and the seal 5 covers the flap portion 3. Therefore, even before the multi-chamber container 1 is used (for example, when the multi-chamber container 1 is transported, etc.), the flap portion 3 can be reliably fixed onto the container body 2 via the seal 5. In addition, unintended operations on the multi-chamber container 1, such as an operator removing the seal 5 blocking the hanging hole 4 before performing an opening operation of the partition portion 23, can be prevented. Furthermore, by fixing the flap portion 3 with the seal 5, damage to the container body 2 caused by the flap portion 3 can be prevented.

[0045] In this embodiment, the size of the seal 5 is 10% to 20% of the size of the container body 2 in the front view, and in addition to the measure 200, the seal 5 is provided with an indication 210 for encouraging mixing of the first medicine and the second medicine. From the viewpoint of visibility, the size of the characters included in the measure 200 and the size of the characters included in the indication 210 in the seal 5 may be 7 pt or more and 72 pt or less. In this case, both the characters included in the measure 200 for mixing the first medicine and the second medicine and the characters included in the indication 210 are easily visible to the user on the seal 5. Therefore, the mixing operation of the first medicine and the second medicine before administration of the medicinal liquid is less likely to be overlooked. In addition, the size of the seal 5 is such that all of the above characters can be written.

[0046] In this embodiment, when the measure 100 is displayed on the surface of the container body 2 and the seal 5 fixes the flap portion 3 onto the container body 2, the orientation of the characters included in the measure 100 displayed on the container body 2 and the orientation of the characters included in the measure 200 displayed on the seal 5 are the same in the up-down direction. Therefore, a user of the multi-chamber container 1 can visually recognize the measures 100 and 200 from either the front side or the back side of the container body 2.

[0047] In this embodiment, since the container body 2, the first drug, and the second drug are transparent, when the container body 2 is folded along the partition portion 23, the measure 100 displayed on the container body 2 and the measure 200 displayed on the sticker 5 are both visible. Therefore, even when the multi-chamber container 1 is folded, the user can easily see the measures 100 and 200.

[0048] In this embodiment, in the container body 2, the first step 101 included in the measure 100 is displayed on the first portion 2c overlapping the first storage section 21 and the central portion 2f overlapping the partition section 23, the second step 102 included in the measure 100 is displayed on the second portion 2d overlapping the second storage section 22, and the partition section 23 may be peeled off by pressing the first portion 2c or the second portion 2d. In this case, even if the first portion 2c or the second portion 2d cannot be seen during the pressing operation by the user, the user can see at least a part of the measure 100. In addition, the third step 103 is also displayed on the third portion 2e overlapping the second storage section 22. This makes it difficult for the user to forget to hang the multi-chamber container 1 on a hook or the like through the hanging hole 4 just by seeing the measure 100.

[0049] Next, a multi-chamber container according to a modified example will be described with reference to Fig. 6. In the description of the modified example, descriptions that overlap with the above-mentioned embodiment will be omitted, and only differences will be described. In other words, to the extent technically possible, the description of the above-mentioned embodiment may be used appropriately in the modified example.

[0050] FIG. 6 is a rear view of a multi-chamber container immediately before use according to a modified example. The multi-chamber container 1A shown in FIG. 6 is different from the multi-chamber container 1 of the above embodiment in that a display 300 is provided on the back surface 3a of the flap portion 3. The back surface 3a of the flap portion 3 is the surface that contacts the container body 2 when the flap portion 3 is folded toward the second storage portion 22, and is the surface opposite to the surface (front surface) of the flap portion 3 to which the seal 5 is attached. Therefore, when the multi-chamber container 1A before use is viewed from the front, the back surface 3a is hidden by the seal 5. On the other hand, the back surface 3a is exposed to the outside in the multi-chamber container 1A immediately before use. The display 300 provided on the back surface 3a is a display (mixing promotion display) that encourages mixing of the first medicine and the second medicine, similar to the display 210 of the above embodiment. In this modified example, the display 300 includes at least one of white letters, symbols, and figures on a red background. The display 300 may be a display that guides the user to mix the first drug solution and the second drug (i.e., to open the partition 23). The display 300 is provided on the opposite side of the seal 5 through the flap portion 3. For this reason, although not shown, when the multi-chamber container 1A before use is viewed from the front, the display 300 is hidden by the seal 5 as well as the back surface 3a. In addition, in the multi-chamber container 1A immediately before use, a part of the seal 5 provided on the front surface of the flap portion 3 is visible in the front view, and in the multi-chamber container 1A immediately before use, the display 300 provided on the back surface 3a of the flap portion 3 is visible in the rear view. The display 300 is, for example, printed directly on the back surface 3a, but is not limited thereto. As shown in FIG. 6, in the multi-chamber container 1A immediately before use, the content of the display 300 is upright in the front view. Therefore, for example, when the multi-chamber container 1 is hung on a hook or the like via the hanging hole 4, the display 300 can fully exhibit its mixing promotion function (attention function) of indicating whether the first drug and the second drug are being mixed. In addition, in this modified example, the first part 300a of the display 300 is provided at one end of the flap part 3 in the direction Y, and the second part 300b of the display 300 is provided at the other end of the flap part 3 in the direction Y, but is not limited to this. The display 300 may have three or more parts, or only one part. The mixing promotion display (second mixing promotion display) shown on the display 300 is the same as the mixing promotion display of the display 210.Display 300 may also include text such as "Unopened, Unusable."

[0051] The above-described modified example also achieves the same effect as the above-described embodiment. In addition, in the multi-chamber container 1A immediately before use, the display 210 is located on the front surface of the container body 2, and the display 300 is located on the back surface of the container body 2. Therefore, the user of the multi-chamber container 1A can see the above-described mixing promotion display (attention display) from either the front side or the back side of the container body 2 after the flap portion 3 is released. In other words, the user of the multi-chamber container 1A can see the display 210 of the seal 5 from the front side of the container body 2, and can see the display 30 from the back side of the container body 2 after the flap portion 3 is released. Therefore, the mixing operation of the first medicine and the second medicine before administration of the medicinal liquid is less likely to be overlooked. That is, it can be said that the modified example has a more improved attention-calling function than the above-described embodiment. Note that, in the above-described modified example, the display 300 is provided on the back surface 3a of the flap portion 3, but this is not limited thereto. For example, the display 300 may be provided on the rear surface of the container body 2 in a portion that is covered and hidden by the flap portion 3 in the multi-chamber container 1A before use.

[0052] Multi-chamber containers according to one aspect of the present invention are as described in the following [1] to

[10] , for example, and have been described in detail based on the above embodiment and the above modified examples. [1] A multi-chamber container having a hanging hole, a container body having a first storage section in which a first drug is stored, a second storage section in which a second drug is stored, and a removable partition section separating the first storage section from the second storage section; A seal covering the hanging hole; Equipped with A method for mixing the first drug and the second drug is displayed on each of the container body and the seal. Multi-chamber container. [2] The multi-chamber container described in [1], wherein the method includes multiple steps for mixing the first drug and the second drug. [3] The seal has a covering portion that covers the hanging hole, The method indicated on the seal further includes a step of peeling off the covering portion to expose the hanging hole. [4] The container further includes a flap portion having the hanging hole and extending from an upper edge of the container body, The multi-chamber container according to any one of [1] to [3], wherein the seal fixes the flap portion onto the container body. [5] The width of the flap portion is smaller than the width of the container body, The seal covers the flap portion. [6] The seal is provided with a first mixing promotion display that promotes mixing of the first drug and the second drug, A multi-chamber container as described in [4] or [5], wherein a second mixing promotion marking for encouraging mixing of the first drug and the second drug is provided on the back surface of the flap portion opposite to the surface to which the seal is attached. [7] When viewed from the front, the size of the seal is 5% to 30% of the size of the container body; In addition to the measures, the seal is provided with a mixing promotion indication for promoting mixing of the first drug and the second drug; The multi-chamber container according to any one of [1] to [6], wherein the size of the characters included in the measure and the size of the characters included in the mixing promotion indication on the sticker are each 7 pt or more and 72 pt or less. [8] The method is displayed on the surface of the container body, A multi-chamber container described in any of [4] to [6], wherein when the seal fixes the flap portion to the container body, the orientation of the letters included in the measure displayed on the container body and the orientation of the letters included in the measure displayed on the seal are identical to each other in the vertical direction. [9] A multi-chamber container as described in [8], wherein when the container body is folded along the partition, the measures displayed on the container body and the measures displayed on the sticker are each visible.

[10] In the container body, a part of the measure is displayed on a first portion overlapping the first storage portion, and another part of the measure is displayed on a second portion overlapping the second storage portion, The multi-chamber container according to [8] or [9], wherein the partition portion is peeled off by compressing the first portion or the second portion.

[0053] However, one aspect of the present invention is not limited to the above embodiment, the above modification, and the above [1] to

[10] . One aspect of the present invention can be further modified within the scope of the gist. For example, in the above embodiment and modification, the seal covers the hanging hole, but this is not limited. For example, the seal may be used only to fix the flap portion and not cover the hanging hole.

[0054] In the above embodiment and the above modified example, the mixing promotion mark is provided on the seal, but this is not limited thereto. For example, the mixing promotion mark may be provided only on the container body instead of the seal, or the mixing promotion mark may be provided on both the seal and the container body. In addition, the third step may be provided only on the seal, or only on the container body.

[0055] In the above embodiment and the above modified example, the container body may further include a bag-shaped small container that contains a medicine different from the first medicine and the second medicine. The small container is provided, for example, inside the first storage section or the second storage section, and has a main body that contains the different medicine, and a partition that separates the inside of the main body from the first storage section or the second storage section. The partition is configured to be peelable in conjunction with the peeling of the partition of the container body. This allows the first medicine, the second medicine, and the different medicine to be mixed well. The container body may include a plurality of small containers. In this case, some of the small containers are provided inside the first storage section, and the other small containers are provided inside the second storage section. The medicine contained in the small container is, for example, a medicine solution containing a surfactant and a fat-soluble vitamin, or a medicine solution containing trace elements such as iron, manganese, zinc, copper, and iodine. [Explanation of symbols]

[0056] 1,1A...multi-chamber container, 2a...one end (upper edge), 2b...outer edge, 2c...first portion (part of measure 100), 2d...second portion (another part of measure 100), 2e...third portion, 2f...central portion, 3...flap portion, 3a...back side, 4...hanging hole, 5...seal, 6...port, 6a...tip, 7...seal, 21...first storage portion, 22...second storage portion, 23...partition portion, 23a...central portion, 23b...side portion, 51...covering portion, 52... Slit, 53...perforation, 54...first area, 54a...first part, 54b...second part, 55...second area, 100...measure, 101...first step, 101a...display, 101b...display, 101c...display, 102...second step, 103...third step, 200...measure, 201...first step, 202...second step, 203...third step, 210...display, 300...display, 300a...first part, 300b...second part.

Claims

1. A multi-chamber container having a hanging hole, a container body having a first storage section in which a first drug is stored, a second storage section in which a second drug is stored, and a removable partition section separating the first storage section from the second storage section; A seal covering the hanging hole; Equipped with A method for mixing the first drug and the second drug is displayed on each of the container body and the seal. Multi-chamber container.

2. The multi-chamber container of claim 1 , wherein the recipe includes multiple steps for mixing the first agent and the second agent.

3. The seal has a covering portion that covers the hanging hole, The multi-chamber container according to claim 1 or 2, wherein the measures indicated on the seal further include a procedure for peeling off the covering portion to expose the hanging hole.

4. The container further includes a flap portion having the hanging hole and extending from an upper edge of the container body, 3. The multi-chamber container according to claim 1, wherein the seal secures the flap portion onto the container body.

5. The width of the flap portion is smaller than the width of the container body, The multi-chamber container of claim 4 , wherein the seal covers the flap portion.

6. The seal is provided with a first mixing promotion display for promoting mixing of the first drug and the second drug, The multi-chamber container according to claim 4 , further comprising a second mixing promotion marking for promoting mixing of the first drug and the second drug on a back surface of the flap portion opposite to the surface to which the sticker is attached.

7. When viewed from the front, the size of the seal is 5% to 30% of the size of the container body, In addition to the measures, the seal is provided with a mixing promotion indication for promoting mixing of the first drug and the second drug; 3. The multi-chamber container according to claim 1, wherein the size of the characters included in the measure and the size of the characters included in the mixing promotion indication on the seal are each 7 pt or more and 72 pt or less.

8. The measures are displayed on the surface of the container body, A multi-chamber container as described in claim 4, wherein when the seal fixes the flap portion to the container body, the orientation of the letters included in the measure displayed on the container body and the orientation of the letters included in the measure displayed on the seal are identical to each other in the vertical direction.

9. The multi-chamber container according to claim 8, wherein when the container body is folded along the partition, the measures displayed on the container body and the measures displayed on the seal are each visible.

10. In the container body, a part of the measure is displayed on a first portion overlapping the first storage section, and another part of the measure is displayed on a second portion overlapping the second storage section, The multi-chamber container according to claim 8 , wherein the partition portion is peeled off by compressing the first portion or the second portion.

Citation Information

Patent Citations

  • Medical multi-chamber container

    JP2007244660A